Celularity Statistics
Total Valuation
Celularity has a market cap or net worth of $42.88 million. The enterprise value is $96.04 million.
Important Dates
The next confirmed earnings date is Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Celularity has 21.98 million shares outstanding. The number of shares has increased by 23.59% in one year.
| Current Share Class | 21.98M |
| Shares Outstanding | 21.98M |
| Shares Change (YoY) | +23.59% |
| Shares Change (QoQ) | +11.72% |
| Owned by Insiders (%) | 15.33% |
| Owned by Institutions (%) | 11.32% |
| Float | 10.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.83 |
| Forward PS | n/a |
| PB Ratio | 1.01 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.35, with a Debt / Equity ratio of 2.11.
| Current Ratio | 0.35 |
| Quick Ratio | 0.24 |
| Debt / Equity | 2.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.99 |
Financial Efficiency
Return on equity (ROE) is -165.13% and return on invested capital (ROIC) is -21.46%.
| Return on Equity (ROE) | -165.13% |
| Return on Assets (ROA) | -13.42% |
| Return on Capital (ROIC) | -21.46% |
| Revenue Per Employee | $279,308 |
| Profits Per Employee | -$1.29M |
| Employee Count | 120 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 3.41 |
Taxes
In the past 12 months, Celularity has paid $10,000 in taxes.
| Income Tax | 10,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.28% in the last 52 weeks. The beta is 0.51, so Celularity's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -16.28% |
| 50-Day Moving Average | 2.49 |
| 200-Day Moving Average | 3.39 |
| Relative Strength Index (RSI) | 42.22 |
| Average Volume (20 Days) | 49,503 |
Short Selling Information
The latest short interest is 680,541, so 3.10% of the outstanding shares have been sold short.
| Short Interest | 680,541 |
| Short Previous Month | 679,173 |
| Short % of Shares Out | 3.10% |
| Short % of Float | 6.21% |
| Short Ratio (days to cover) | 34.11 |
Income Statement
In the last 12 months, Celularity had revenue of $33.52 million and -$154.29 million in losses. Loss per share was -$8.00.
| Revenue | 33.52M |
| Gross Profit | 17.86M |
| Operating Income | -54.36M |
| Pretax Income | -196.29M |
| Net Income | -154.29M |
| EBITDA | -45.24M |
| EBIT | -54.36M |
| Loss Per Share | -$8.00 |
Full Income StatementBalance Sheet
The company has $1.90 million in cash and $66.07 million in debt, giving a net cash position of -$64.16 million or -$2.92 per share.
| Cash & Cash Equivalents | 1.90M |
| Total Debt | 66.07M |
| Net Cash | -64.16M |
| Net Cash Per Share | -$2.92 |
| Equity (Book Value) | 31.25M |
| Book Value Per Share | 1.43 |
| Working Capital | -43.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$28.09 million and capital expenditures -$878,000, giving a free cash flow of -$28.97 million.
| Operating Cash Flow | -28.09M |
| Capital Expenditures | -878,000 |
| Free Cash Flow | -28.97M |
| FCF Per Share | -$1.32 |
Full Cash Flow StatementMargins
| Gross Margin | 53.30% |
| Operating Margin | -162.19% |
| Pretax Margin | -460.31% |
| Profit Margin | n/a |
| EBITDA Margin | -134.99% |
| EBIT Margin | -162.19% |
| FCF Margin | -174.49% |